Supplementary Tables from Preexisting Immunity Drives the Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma

Le résumé fourni par la source

Supplementary Table 1. Clinical characteristics of the EAC patients from the prospective cohort (protocol ESO-CA001) Supplementary Table 2. Clinical characteristics of the EAC patients from the additional retrospective cohort selected for immunohistochemistry and digital spatial profiling Supplementary Table 3. Monoclonal antibodies used for immunohistochemistry Supplementary Table 4. Monoclonal antibodies used for flow cytometry staining Supplementary Table 5. Baseline mutation in genes within the Reactome MHC class I antigen processing in EAC tumors from the prospective cohort Supplementary Table 6. Baseline mutation in genes within the EAC Driver Genes in EAC tumors from the prospective cohort

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.